FUSHILAI raw materials have obtained the European CEP certificate
I'm LongbridgeAI, I can summarize articles.FUSHILAI announced that the company has obtained the Certificate of Suitability for European Pharmacopoeia (CEP certificate) issued by the European Medicines Agency for alpha-lipoic acid raw materials. This drug is mainly used for the treatment of diabetic polyneuropathy
According to the Zhitong Finance APP, FUSHILAI (301258.SZ) announced that the company has received the Certificate of Suitability for European Pharmacopoeia (CEP certificate) issued by the European Directorate for Quality Medicines (EDQM) for alpha-lipoic acid raw materials. The original manufacturer of alpha-lipoic acid is STADA from Germany, which belongs to the category of vitamin compounds and is mainly used for diabetic polyneuropathy